Nuravax
Our mission is to develop effective and affordable preventive vaccines for Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders. Using our universal vaccine platform for Alzheimer’s, our goal is to induce antibody titers high enough to penetrate the blood-brain barrier and prevent pathological plaques, fibrils, and oligomers to delay disease onset in cognitively unimpaired people at risk of Alzheimer’s.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
3
11 to 50 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Nuravax
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- AG
Anahit Ghochikyan
Chief Scientific Officer · Science
EmailPhone - JE
James E. Callaway
Head of Development · Research & Development
EmailPhone - RK
Roman Kniazev
() · Other
EmailPhone
Showing 3 of 3 verified contacts
Top roles at Nuravax
3 distinct titles indexed · top 3 shown.
- 1()
- 1chief scientific officer
- 1head of development
Sign up to unlock all 3 contacts at Nuravax
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Nuravax
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.